Patient Guide: A Microdose Trial Investigating Binding of [68Ga]Ga-DOTA-CYS-ATH001 in Healthy Subjects and Different Patient Groups.

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 3 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT06562361
Status: 🟢 Enrolling Now
Condition: MASH, PSC, Fibrostenotic Crohn's Disease, Healthy Volunteers
Phase: EARLY_PHASE1

Find a Study Location Near You

This study is available at 3 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Stockholm,
  • • Uppsala,
  • • Uppsala,

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Microdose Trial Investigating Binding of [68Ga]Ga-DOTA-CYS-ATH001 in Healthy Subjects and Different Patient Groups. - Join Clinical Trial NCTNCT06562361

How to Join This Clinical Trial - NCTNCT06562361

Learn how to participate in this EARLY_PHASE1 trial studying an investigational therapy for MASH, PSC, Fibrostenotic Crohn's Disease, Healthy Volunteers. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with MASH, PSC, Fibrostenotic Crohn's Disease, Healthy Volunteers. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
MASH, PSC, Fibrostenotic Crohn's Disease, Healthy Volunteers
Treatment Being Tested
Investigational treatment
Study Phase
EARLY_PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06562361 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 3 locations. Find a study site near you:

Clinical Research Site

Stockholm, SE-171 64 S - Sweden

Status: RECRUITING

Clinical Research Site

Uppsala, SE-751 85 - Sweden

Status: NOT_YET_RECRUITING

Clinical Research Site

Uppsala, SE-751 85 - Sweden

Status: NOT_YET_RECRUITING

How to Enroll in This Study

To learn more about participating in this EARLY_PHASE1 clinical trial for MASH, PSC, Fibrostenotic Crohn's Disease, Healthy Volunteers:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation